CAMPI, IRENE
CAMPI, IRENE
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Unusual causes of hyperthyrotropinemia and differential diagnosis of primary hypothyroidism: a revised diagnostic flowchart
2023 I. Campi, M. Dell’Acqua, E.S. Grassi, M.C.E. Vigone, L. Persani
Variation in Thyroid Hormone Metabolism May Affect COVID-19 Outcome
2022 L. Persani, I. Campi
Tissue sensitivity to thyroid hormones may change over time
2022 G. Radetti, F. Rigon, A. Salvatoni, I. Campi, T. De Filippis, V. Cirello, S. Longhi, F. Guizzardi, M. Bonomi, L. Persani
Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy
2022 I. Campi, G. Vannucchi, I. Muller, E. Lazzaroni, N. Currò, M. Dainese, B. Montacchini, D. Covelli, C. Guastella, L. Pignataro, L. Fugazzola, M. Arosio, M. Salvi
The spectrum of thyroid function tests during hospitalization for SARS COV-2 infection
2021 I. Campi, I. Bulgarelli, A. Dubini, G.B. Perego, E. Tortorici, C. Torlasco, E. Torresani, L. Rocco, L. Persani, L. Fugazzola
The relationship between liver histology and thyroid function tests in patients with nonalcoholic fatty liver disease (NAFLD)
2021 R. D'Ambrosio, I. Campi, M. Maggioni, R. Perbellini, E. Giammona, R. Stucchi, M. Borghi, E. Degasperi, A. De Silvestri, L. Persani, L. Fugazzola, P. Lampertico
A rare mutation of thyroid hormone receptor beta gene in thyroid hormone resistance syndrome
2021 M. Del Prete, F. Muratori, I. Campi, G. Di Sacco, F. Vignati, D. Pellegrino, L. Persani
Clinical consequences of variable results in the measurement of free thyroid hormones : unusual presentation of a family with a novel variant in the THRB gene causing resistance to thyroid hormone syndrome
2021 I. Campi, M. Agostini, F. Marelli, T. De Filippis, B. Romartinez-Alonso, O. Rajanayagam, G. Rurale, I. Gentile, F. Spagnolo, M. Andreasi, F. Ferrau, S. Cannavo, L. Fugazzola, K.V. Chatterjee, L. Persani
Quantification of global ocular motility impairment in graves' orbitopathy by measuring eye muscle ductions
2021 I. Campi, N. Currò, G. Vannucchi, D. Covelli, S. Simonetta, L. Fugazzola, L. Pignataro, D. Dazzi, C. Guastella, E. Lazzaroni, G. Pirola, M. Salvi
Vitamin D and COVID-19 severity and related mortality : a prospective study in Italy
2021 I. Campi, L. Gennari, D. Merlotti, C. Mingiano, A. Frosali, L. Giovanelli, C. Torlasco, M.F. Pengo, F. Heilbron, D. Soranna, A. Zambon, M. Di Stefano, C. Aresta, M. Bonomi, B. Cangiano, V. Favero, L. Fatti, G.B. Perego, I. Chiodini, G. Parati, L. Persani
Efficacy profile and safety implications of very low dose Rituximab in patients with graves' orbitopathy
2021 G.M. Vannucchi, I. Campi, D. Covelli, N. Curro, E. Lazzaroni, A. Palomba, D. Soranna, A. Zambon, L. Fugazzola, I. Muller, C. Guastella, M. Salvi
Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy.
2020 G. Lanzolla, G. Vannucchi, I. Ionni, I. Campi, F. Sileo, E. Lazzaroni, M. Marinò
The Differential Diagnosis of Discrepant Thyroid Function Tests: Insistent Pitfalls and Updated Flow-Chart Based on a Long-Standing Experience
2020 I. Campi, D. Covelli, C. Moran, L. Fugazzola, C. Cacciatore, F. Orlandi, G. Gallone, K. Chatterjee, P. Beck-Peccoz, L. Persani
Syndromes of Resistance to Thyroid Hormone Action
2019 L. Persani, I. Campi
Pulsed intravenous methylprednisolone combined with oral steroids as a treatment for poorly responsive type 2 amiodarone-induced thyrotoxicosis
2019 I. Campi, G. Perego, A. Ravogli, A. Groppelli, G. Parati, L. Persani, L. Fugazzola
Prevention of orbitopathy by oral or intravenous steroid prophylaxis in short duration Graves’ disease patients undergoing radioiodine ablation : A prospective randomized control trial study
2019 G. Vannucchi, D. Covelli, I. Campi, N. Curro, D. Dazzi, M. Rodari, G. Pepe, A. Chiti, C. Guastella, E. Lazzaroni, M. Salvi
Severe Graves' Orbitopathy occurring in a patient with thyroid hemiagenesis
2018 D. Meringolo, I. Campi, G. Costante
Retinal photoreceptor functions are compromised in patients with resistance to thyroid hormone syndrome (RTHβ)
2017 I. Campi, G. Cammarata, S. Bianchi Marzoli, P. Beck-Peccoz, D. Santarsiero, D. Dazzi, A. Bottari de Castello, E.G. Taroni, F. Viola, C. Mian, S. Watuntantrige Fernando, C. Pelusi, M. Muzza, M.A. Maffini, L. Persani
Therapy of endocrine disease : Endocrine dilemma : management of Graves' orbitopathy
2016 I. Campi, G. Vannucchi, M. Salvi
Statins may increase the risk of liver dysfunction in patients treated with steroids for active graves' orbitopathy
2015 D. Covelli, G. Vannucchi, I. Campi, N. Currò, R. D'Ambrosio, M. Maggioni, U. Gianelli, P. Beck-Peccoz, M. Salvi